| # | Question | Field Format |
|---|---|---|
| Section 1: Demographic Information | ||
| 1.01 | Age | • 20–29 • 30–39 • 40–49 • 50–59 • 60–69 • 70+ |
| 1.02 | Sex | • Male • Female • Other |
| 1.03a | Country | • Malaysia • Thailand • Philippines • Gulf Cooperation Council (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman) • Egypt • South Africa • Brazil • Mexico • Argentina |
| 1.03b | Region/State (specific to each country) | |
| 1.04 | What is your role as a frontline healthcare worker? | • General practitioner/family physician/family medicine specialist • Other medical specialist • Pharmacist |
| 1.05 | What qualification/specialty do you have? (check all that apply) | • Medical degree • General practice/family medicine • Internal/general medicine • Psychiatry • Cardiology • Endocrinology • Pharmacy degree |
| 1.06 | What type of practice/clinic/pharmacy is your main place of work? | • Privately owned practice/clinic • Government-owned practice/clinic • Commercially owned practice/clinic (large corporate) • Community-owned practice/clinic • NGO-owned practice/clinic • District hospital • Regional hospital • Secondary/tertiary hospital |
| 1.06a | If ‘pharmacist’ selected in 1.04 How would you classify your workplace/role? | • Owner operator of community pharmacy • Work for owner of community pharmacy • Work for a chain pharmacy • Pharmacist at a hospital • Clinical pharmacist on a ward • Head of pharmacy at a NGO clinic |
| 1.07 | Is your primary practice/clinic located in an urban or rural setting? | • Rural • Urban |
| 1.08 | How are you currently seeing patients? | • In person • Remotely (e.g. video consults, telephone consults, email, messaging, home delivery of medicine/devices), • Both remotely and in person • Unable to see patients due to public health restrictions |
| Section 2: Clinical Practice | ||
| Question | Rationale | |
| 2.01 | Prior to the COVID-19 pandemic, what proportion of your patients would you say had or were provided treatment for cardiovascular diseases (including hypertension and raised lipids) and/or diabetes? | • Less than 20% • 21%–40% • 41%–60% • 61%–80% • More than 80% |
| 2.02 | Prior to the COVID-19 pandemic, what proportion of your patients would you say had or were provided treatment for depression or anxiety? | • Less than 20% • 21%–40% • 41%–60% • 61%–80% • More than 80% |
| 2.03 | Since the COVID-19 pandemic, has there been any change in the number of patients that seek care relating to NCDs or mental health? | |
| 2.03a | Hypertension | • Number of patients seeking care increased • No change in number of patients seeking care • Number of patients seeking care decreased |
| 2.03b | Raised lipids | • Number of patients seeking care increased • No change in number of patients seeking care • Number of patients seeking care decreased |
| 2.03c | Diabetes | • Number of patients seeking care increased • No change in number of patients seeking care • Number of patients seeking care decreased |
| 2.03d | Depression and/or anxiety | • Number of patients seeking care increased • No change in number of patients seeking care • Number of patients seeking care decreased |
| 2.03e | Show if respondent select “increase” If there has been an increase, has the increase been in new patients or existing patients? | • Increase in new patients • Existing patients seeking more care • Both |
| 2.04 | To what extent do you believe that COVID-19 has adversely affected the mental health of your patients? | • Yes – most patients affected • Yes – some patients affected • No – stayed the same, • No – mental health improved |
| 2.05 | Has there been any change in the severity of the condition of patients seeking care for NCDs or mental health? | • Severity of the condition of patients has increased • No change in severity • Severity of the condition of patients has decreased |
| 2.06 | What effect has the COVID-19 pandemic had on your ability to provide care to your patients with NCDs? | • Care has improved • No change in care, • Care has deteriorated |
| 2.07 | What effect has the COVID-19 pandemic had on your ability to provide care to your patients with depression or anxiety? | • Care has improved • No change in care • Care has deteriorated |
| 2.08 | To what extent has your clinical or patient care activities been limited by public health measures (e.g. lockdown/quarantine, use of PPE, travel restrictions, etc.) related to COVID-19? | • Not at all • Somewhat impacted • Moderately impacted • Significantly impacted |
| 2.09 | Overall, have you observed any changes in your patients’ self-care during the COVID-19 pandemic? | • Increased • No change • Decreased • Don’t know |
| 2.10 | Which of the following factors relating to the COVID-19 pandemic are influencing care of your patients? (check as many as apply) | • Delayed treatment for non-COVID-19 conditions • Unable to have in-person consultations with you • Loss of continuity of care • Difficulty accessing at-distance (e.g. phone or video) care • Less access to physical examination and monitoring such as blood pressure and weight • Less access to medications (e.g. shortages) • Less access to laboratory tests • Less access to secondary care referrals • Reluctance of patients to visit healthcare settings during pandemic • Lack of clinic/pharmacy staff • Increased workload due to COVID-19 response measures |
| 2.11 | What barriers, if any, do you believe that patients may experience in accessing routine care during the COVID-19 pandemic? (Check all that apply) | • Restriction of movement • Financial hardships or loss of insurance • Lack of transport • Lack of childcare • Clinic closures • Lack of access to healthy food • Medication rationing • Medication shortages • Physical displacement • Lack of communication infrastructure • Unrelated health burdens • Fear of contracting COVID-19 in healthcare settings • No barriers • Other barriers |
| \Section 3: Innovation | ||
| Question | Field Format | |
| 3.01 | What technology innovation changes do you think will be likely following the COVID-19 pandemic? (check all that apply) | • Increased use of teleconsulting/virtual consulting • Increased use of electronic prescriptions • E-therapy, digital therapeutics • Use of wearable monitors • Mobile health for self-management • None of the above |
| 3.02 | What healthcare practices would you be interested in adopting following the COVID-19 pandemic? | • Patient counselling • Adherence management • Cardiovascular risk assessment • Medication management • Preventative activities • Teleconsulting/Virtual consulting • None of the above |
| 3.03 | How useful did you find technology in managing routine care of NCDs during the COVID-19 pandemic? | • Not useful at all • Not useful • Neither useful nor not useful • Useful • Very useful |
| 3.04 | Has there been any change in the number of patients interested in or purchasing devices related to self-care or self-monitoring of NCDs such as glucometers, blood pressure monitors, oximeters? | • Increased • No change • Decreased |
Thank you for participating in this survey.